Journal :   Research Journal of Pharmacy and Technology

Volume No. :   11

Issue No. :  12

Year :  2018

Pages :   5405-5407

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Registration

Allready Registrered
Click to Login

Evaluation of Cardio-Vascular Risk in Children with Developmental Coordination Disorder in Indian Context- Pilot Study



Address:   Dr. U. Ganapathy Sankar1, Monisha. R2
1Professor and Dean, SRM College of Occupational Therapy, SRM Institute of Science and Technology, India
2Assistant Professor, SRM College Of Physiotherapy, SRM Institute of Science and Technology, India
*Corresponding Author
DOI No: 10.5958/0974-360X.2018.00986.1

ABSTRACT:
Introduction: Children with DCD experiences social isolation and psycho-somatic dysfunction. Because of the social isolation and poor motor coordination, these children have no participation in physical activities and in sports. Objective: Objective of the current study is to assess the cardio vascular risk in children with DCD. Mathodology: Baseline evaluation of the children motor coordination has been completed by using DCDQ.A total of 20 children were assessed in the baseline using DCDQ, Cardio respiratory fitness has been evaluated indirectly by assessing 5 Sit to stand test and 6 minute run or walk test. Discussion: Participants were recruited based on the basis of DCDQ score. In BMI, all these children with DCD has increased body mass as related to their age predicted values and this leads to a reduction in participation in physical activity with their peer groups there was a statistically significant difference found in 5STS and 6MWT. Conclusion: This pilot study reveals that motor impairment and poor physical activity with increased BMI is responsible for the CVD.
KEYWORDS:
Developmental coordination disorder, cardio-vascular risk, six minute walk test, sit to stand test.
Cite:
U. Ganapathy Sankar, Monisha. R. Evaluation of Cardio-Vascular Risk in Children with Developmental Coordination Disorder in Indian Context- Pilot Study. Research J. Pharm. and Tech 2018; 11(12): 5405-5407.
[View HTML]     



Visitor's No. :   499883